US65344D2080 - Common Stock
NexImmune just reported results for the fourth quarter of 2023.
NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules...
NexImmune (NEXI) stock traded lower Friday after announcing an agreement to sell common stock to raise $3.67M in gross proceeds. Read more here.
NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules...
We're starting the trading week with a breakdown of the biggest pre-market stock movers worth knowing about on Monday!
The biggest pre-market stock movers for Wednesday are ready to go as we break down all of the latest news moving shares today!
NEXI stock is rising higher ahead of a potential liquidation and dissolution of NexImmune. Here's what you need to know.
Although NexImmune seeks to dissolve its business, NEXI stock is skyrocketing, leading to questions regarding the catalyst.